Cargando…

Respiratory Disease following Viral Lung Infection Alters the Murine Gut Microbiota

Alterations in the composition of the gut microbiota have profound effects on human health. Consequently, there is great interest in identifying, characterizing, and understanding factors that initiate these changes. Despite their high prevalence, studies have only recently begun to investigate how...

Descripción completa

Detalles Bibliográficos
Autores principales: Groves, Helen T., Cuthbertson, Leah, James, Phillip, Moffatt, Miriam F., Cox, Michael J., Tregoning, John S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816042/
https://www.ncbi.nlm.nih.gov/pubmed/29483910
http://dx.doi.org/10.3389/fimmu.2018.00182
_version_ 1783300603870445568
author Groves, Helen T.
Cuthbertson, Leah
James, Phillip
Moffatt, Miriam F.
Cox, Michael J.
Tregoning, John S.
author_facet Groves, Helen T.
Cuthbertson, Leah
James, Phillip
Moffatt, Miriam F.
Cox, Michael J.
Tregoning, John S.
author_sort Groves, Helen T.
collection PubMed
description Alterations in the composition of the gut microbiota have profound effects on human health. Consequently, there is great interest in identifying, characterizing, and understanding factors that initiate these changes. Despite their high prevalence, studies have only recently begun to investigate how viral lung infections have an impact on the gut microbiota. There is also considerable interest in whether the gut microbiota could be manipulated during vaccination to improve efficacy. In this highly controlled study, we aimed to establish the effect of viral lung infection on gut microbiota composition and the gut environment using mouse models of common respiratory pathogens respiratory syncytial virus (RSV) and influenza virus. This was then compared to the effect of live attenuated influenza virus (LAIV) vaccination. Both RSV and influenza virus infection resulted in significantly altered gut microbiota diversity, with an increase in Bacteroidetes and a concomitant decrease in Firmicutes phyla abundance. Although the increase in the Bacteroidetes phylum was consistent across several experiments, differences were observed at the family and operational taxonomic unit level. This suggests a change in gut conditions after viral lung infection that favors Bacteroidetes outgrowth but not individual families. No change in gut microbiota composition was observed after LAIV vaccination, suggesting that the driver of gut microbiota change is specific to live viral infection. Viral lung infections also resulted in an increase in fecal lipocalin-2, suggesting low-grade gut inflammation, and colonic Muc5ac levels. Owing to the important role that mucus plays in the gut environment, this may explain the changes in microbiota composition observed. This study demonstrates that the gut microbiota and the gut environment are altered following viral lung infections and that these changes are not observed during vaccination. Whether increased mucin levels and gut inflammation drive, or are a result of, these changes is still to be determined.
format Online
Article
Text
id pubmed-5816042
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-58160422018-02-26 Respiratory Disease following Viral Lung Infection Alters the Murine Gut Microbiota Groves, Helen T. Cuthbertson, Leah James, Phillip Moffatt, Miriam F. Cox, Michael J. Tregoning, John S. Front Immunol Immunology Alterations in the composition of the gut microbiota have profound effects on human health. Consequently, there is great interest in identifying, characterizing, and understanding factors that initiate these changes. Despite their high prevalence, studies have only recently begun to investigate how viral lung infections have an impact on the gut microbiota. There is also considerable interest in whether the gut microbiota could be manipulated during vaccination to improve efficacy. In this highly controlled study, we aimed to establish the effect of viral lung infection on gut microbiota composition and the gut environment using mouse models of common respiratory pathogens respiratory syncytial virus (RSV) and influenza virus. This was then compared to the effect of live attenuated influenza virus (LAIV) vaccination. Both RSV and influenza virus infection resulted in significantly altered gut microbiota diversity, with an increase in Bacteroidetes and a concomitant decrease in Firmicutes phyla abundance. Although the increase in the Bacteroidetes phylum was consistent across several experiments, differences were observed at the family and operational taxonomic unit level. This suggests a change in gut conditions after viral lung infection that favors Bacteroidetes outgrowth but not individual families. No change in gut microbiota composition was observed after LAIV vaccination, suggesting that the driver of gut microbiota change is specific to live viral infection. Viral lung infections also resulted in an increase in fecal lipocalin-2, suggesting low-grade gut inflammation, and colonic Muc5ac levels. Owing to the important role that mucus plays in the gut environment, this may explain the changes in microbiota composition observed. This study demonstrates that the gut microbiota and the gut environment are altered following viral lung infections and that these changes are not observed during vaccination. Whether increased mucin levels and gut inflammation drive, or are a result of, these changes is still to be determined. Frontiers Media S.A. 2018-02-12 /pmc/articles/PMC5816042/ /pubmed/29483910 http://dx.doi.org/10.3389/fimmu.2018.00182 Text en Copyright © 2018 Groves, Cuthbertson, James, Moffatt, Cox and Tregoning. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Groves, Helen T.
Cuthbertson, Leah
James, Phillip
Moffatt, Miriam F.
Cox, Michael J.
Tregoning, John S.
Respiratory Disease following Viral Lung Infection Alters the Murine Gut Microbiota
title Respiratory Disease following Viral Lung Infection Alters the Murine Gut Microbiota
title_full Respiratory Disease following Viral Lung Infection Alters the Murine Gut Microbiota
title_fullStr Respiratory Disease following Viral Lung Infection Alters the Murine Gut Microbiota
title_full_unstemmed Respiratory Disease following Viral Lung Infection Alters the Murine Gut Microbiota
title_short Respiratory Disease following Viral Lung Infection Alters the Murine Gut Microbiota
title_sort respiratory disease following viral lung infection alters the murine gut microbiota
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816042/
https://www.ncbi.nlm.nih.gov/pubmed/29483910
http://dx.doi.org/10.3389/fimmu.2018.00182
work_keys_str_mv AT groveshelent respiratorydiseasefollowingvirallunginfectionaltersthemurinegutmicrobiota
AT cuthbertsonleah respiratorydiseasefollowingvirallunginfectionaltersthemurinegutmicrobiota
AT jamesphillip respiratorydiseasefollowingvirallunginfectionaltersthemurinegutmicrobiota
AT moffattmiriamf respiratorydiseasefollowingvirallunginfectionaltersthemurinegutmicrobiota
AT coxmichaelj respiratorydiseasefollowingvirallunginfectionaltersthemurinegutmicrobiota
AT tregoningjohns respiratorydiseasefollowingvirallunginfectionaltersthemurinegutmicrobiota